AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 223 filers reported holding AMICUS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,446,000 | +8.8% | 283,400 | +12.4% | 0.00% | 0.0% |
| Q2 2023 | $3,168,000 | +8.2% | 252,174 | -4.6% | 0.00% | 0.0% |
| Q1 2023 | $2,929,000 | -15.9% | 264,202 | -7.4% | 0.00% | 0.0% |
| Q4 2022 | $3,483,000 | +71.6% | 285,335 | +46.8% | 0.00% | 0.0% |
| Q3 2022 | $2,030,000 | +0.1% | 194,366 | +3.0% | 0.00% | 0.0% |
| Q2 2022 | $2,027,000 | +15.8% | 188,782 | +2.2% | 0.00% | – |
| Q1 2022 | $1,750,000 | -25.8% | 184,769 | -9.5% | 0.00% | -100.0% |
| Q4 2021 | $2,357,000 | +55.9% | 204,106 | +29.0% | 0.00% | – |
| Q3 2021 | $1,512,000 | +7.0% | 158,227 | +8.0% | 0.00% | – |
| Q2 2021 | $1,413,000 | +3.1% | 146,570 | +5.6% | 0.00% | – |
| Q1 2021 | $1,370,000 | +113.4% | 138,772 | +400.0% | 0.00% | – |
| Q4 2020 | $642,000 | +88.3% | 27,755 | +14.8% | 0.00% | – |
| Q3 2020 | $341,000 | +79.5% | 24,183 | +92.1% | 0.00% | – |
| Q2 2020 | $190,000 | -35.6% | 12,588 | -60.5% | 0.00% | – |
| Q1 2020 | $295,000 | -76.4% | 31,884 | -75.1% | 0.00% | – |
| Q4 2019 | $1,248,000 | +20.9% | 128,194 | -0.4% | 0.00% | – |
| Q3 2019 | $1,032,000 | -33.2% | 128,755 | +4.0% | 0.00% | -100.0% |
| Q2 2019 | $1,545,000 | -12.8% | 123,819 | -5.0% | 0.00% | 0.0% |
| Q1 2019 | $1,772,000 | -64.0% | 130,301 | -74.6% | 0.00% | -50.0% |
| Q4 2018 | $4,920,000 | -7.4% | 513,566 | +16.9% | 0.00% | 0.0% |
| Q3 2018 | $5,311,000 | +3.6% | 439,300 | +33.8% | 0.00% | 0.0% |
| Q2 2018 | $5,128,000 | +6.9% | 328,265 | +2.9% | 0.00% | 0.0% |
| Q1 2018 | $4,796,000 | -29.2% | 318,869 | -32.3% | 0.00% | -33.3% |
| Q4 2017 | $6,777,000 | -8.0% | 471,009 | -3.6% | 0.00% | -25.0% |
| Q3 2017 | $7,368,000 | -21.1% | 488,576 | -47.3% | 0.00% | -20.0% |
| Q2 2017 | $9,333,000 | +41.3% | 926,796 | +0.0% | 0.01% | +25.0% |
| Q1 2017 | $6,605,000 | +11487.7% | 926,546 | +8030.4% | 0.00% | – |
| Q4 2016 | $57,000 | +147.8% | 11,396 | +261.5% | 0.00% | – |
| Q3 2016 | $23,000 | +2200.0% | 3,152 | +3052.0% | 0.00% | – |
| Q2 2016 | $1,000 | -97.9% | 100 | -97.1% | 0.00% | – |
| Q3 2015 | $47,000 | -93.2% | 3,422 | -93.0% | 0.00% | – |
| Q2 2015 | $696,000 | +5253.8% | 49,200 | +4000.0% | 0.00% | – |
| Q1 2015 | $13,000 | +1200.0% | 1,200 | +117.4% | 0.00% | – |
| Q3 2013 | $1,000 | – | 552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |